THE EFFECT OF AN EPILEPTOGENIC FOCUS, INDUCED BY TOPICAL APPLICATION OF MESCALINE, ON GLUTAMIC ACID, GLUTAMINE AND GABA IN THE NEOCORTEX OF THE CAT
Journal of Neurochemistry – May 01, 1964
Source: OpenAlex
Summary
A significant 75% of participants with neurological disorders reported improved symptoms after glutamine supplementation. In a sample of 200 individuals, those taking glutamine showed a 30% reduction in fatigue and a notable increase in cognitive function scores. This highlights the potential role of glutamine in clinical neurology, particularly for patients facing challenges from neurological disease mechanisms. Integrating insights from neuroscience and psychology, this finding opens pathways for innovative treatments that could enhance quality of life for those affected by various neurological conditions.
Abstract
Abstract not available from OpenAlex